Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oshadi D and Oshadi R in Basal Cell Carcinoma
NCT02007317Phase 2Completed
- Sponsor
- Oshadi Drug Administration Ltd.
- Start
- Nov 2013
- Primary completion
- Mar 2017
- Modality
- Nanoparticles, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Deoxyribonuclease in Oshadi carrier, oshadi r in basal cell carcinoma (BCC), sponsored by Oshadi Drug Administration Ltd.. Started Nov 2013; status: completed.
02
Drugs
Deoxyribonuclease in Oshadi carrieroshadi r
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on NCT02007317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02007317.